Medicare Enrolled

Dr. Miranda Hardee, MD

Urology Physician · Austin, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11410 JOLLYVILLE RD STE 1101, Austin, TX 78759
5122311444
In practice since 2008 (17 years)
NPI: 1912151150 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hardee from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hardee? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hardee

Dr. Miranda Hardee is an urology physician in Austin, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Hardee performed 9,316 Medicare services across 1,891 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hardee received a total of $8,081 from 52 pharmaceutical and/or device companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hardee is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 11% volume in TX $8,081 industry payments

Medicare Practice Summary

Medicare Utilization ↗
9,316
Medicare services
Top 11% in TX for urology physician
1,891
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~548 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit 5,900 $5 $14
Automated urinalysis 802 $2 $7
Office visit, established patient (30-39 min) 755 $92 $249
Chronic care management, first 20 min/month 663 $49 $77
Bladder ultrasound after voiding 406 $8 $44
Chronic care management, additional 20 min/month 316 $38 $77
New patient office visit (45-59 min) 142 $117 $380
Diagnostic exam of bladder and urethra using an endoscope 85 $180 $477
Office visit, established patient (20-29 min) 67 $62 $168
Exam with injections of chemical for destruction of bladder using an endoscope 44 $303 $726
Blood draw (venipuncture) 39 $8 $15
Simple bladder irrigation and/or instillation 29 $47 $194
Insertion of peripheral or gastric neurostimulator generator 16 $126 $621
Insertion of sacral nerve neurostimulator electrode array 15 $246 $1,923
Insertion of temporary bladder tube 13 $36 $127
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm 12 $140 $1,617
Ct scan of abdomen and pelvis without contrast 12 $76 $347
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,081
Total received (2018-2024)
Avg $1,154/year across 7 years
Top 24% in TX for urology physician
52
Companies
444
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,667 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$414 (5.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,499
2023
$1,487
2022
$1,029
2021
$1,211
2020
$846
2019
$945
2018
$1,064

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$838
Janssen Biotech, Inc.
$692
Astellas Pharma US Inc
$689
Sumitomo Pharma America, Inc.
$476
Allergan, Inc.
$387
Antares Pharma, Inc.
$374
PFIZER INC.
$318
AMAG Pharmaceuticals, Inc.
$288
Dendreon Pharmaceuticals LLC
$269
Allergan Inc.
$233
Teleflex LLC
$213
UROVANT SCIENCES INC
$203
Amgen Inc.
$197
AbbVie, Inc.
$192
TherapeuticsMD, Inc.
$173
Medtronic, Inc.
$171
Endo Pharmaceuticals Inc.
$154
Novartis Pharmaceuticals Corporation
$143
Olympus America Inc.
$139
Myovant Sciences Inc.
$126
Clarus Therapeutics Inc.
$109
Axonics, Inc.
$105
Bayer HealthCare Pharmaceuticals Inc.
$104
Myriad Genetic Laboratories, Inc.
$102
Medtronic USA, Inc.
$101
AbbVie Inc.
$85
Innovation Technologies Inc
$85
BLUEWIND MEDICAL
$78
Tolmar, Inc.
$77
Bayer Healthcare Pharmaceuticals Inc.
$71
Blue Earth Diagnostics Limited
$68
Laborie Medical Technologies Corp.
$65
Supernus Pharmaceuticals, Inc.
$63
Boston Scientific Corporation
$58
COLOPLAST CORP
$58
MILLICENT US INC
$55
Merck Sharp & Dohme LLC
$52
ConvaTec Inc.
$48
NeoTract Inc.
$47
Merck Sharp & Dohme Corporation
$44
ACCORD HEALTHCARE, INC.
$44
AstraZeneca Pharmaceuticals LP
$41
BOSTON SCIENTIFIC CORPORATION
$37
Dornier MedTech America, Inc
$35
Acerus Pharmaceuticals Corporation
$35
TOLMAR Pharmaceuticals, Inc.
$31
Duchesnay USA Incorporated
$22
UroGen Pharma, Inc.
$20
Novo Nordisk Inc
$20
Inspire Medical Systems, Inc.
$18
Clovis Oncology, Inc.
$16
Profound Medical Corp.
$12
Top 3 companies account for 27.5% of total payments
Associated products mentioned in payments ›
AFINITOR · AVEED · AVYCAZ · Altis · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · ELIGARD · ERLEADA · Erleada · GEMTESA · GENTLECATH · IMVEXXY · INSPIRE · INTERSTIM · INTRAROSA · IRRISEPT · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lithotripters & Accessories · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Nubeqa · ORGOVYX · OTREXUP · Optilume BPH Drug Coated Balloon Catheter · Osphena · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Prolia · REVI · Rivfloza · Rubraca · SOLESTA · SPACEOAR · SPACEOAR VUE · TLANDO · ULTRASOUND PROBE · UROLIFT · UroLift · UroLift System · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $87 per 100 Medicare services performed
Looking for an urology physician in Austin?
Compare urology physicians in the Austin area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
68
Per 100K population
5.2
County median income
$97,169
Nearest hospital
ASCENSION SETON NORTHWEST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hardee is a clinical cardiology specialist, with above-average Medicare volume (top 11% in TX), with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hardee experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Hardee performed 5,900 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hardee receive payments from pharmaceutical companies?
Yes. Dr. Hardee received a total of $8,081 from 52 companies across 444 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hardee's costs compare to other urology physicians in Austin?
Dr. Hardee's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hardee) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →